• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Signatures and Discriminative Abilities of Multi-Omics between States of Cognitive Decline.认知衰退状态之间多组学的特征与鉴别能力
Biomedicines. 2024 Apr 23;12(5):941. doi: 10.3390/biomedicines12050941.
2
Optimal combinations of CSF biomarkers for predicting cognitive decline and clinical conversion in cognitively unimpaired participants and mild cognitive impairment patients: A multi-cohort study.最优组合的 CSF 生物标志物预测认知下降和临床转化在认知正常的参与者和轻度认知障碍患者:多队列研究。
Alzheimers Dement. 2023 Jul;19(7):2943-2955. doi: 10.1002/alz.12907. Epub 2023 Jan 17.
3
An integrative multi-omics approach reveals new central nervous system pathway alterations in Alzheimer's disease.一种综合的多组学方法揭示了阿尔茨海默病中中枢神经系统新的通路改变。
Alzheimers Res Ther. 2021 Apr 1;13(1):71. doi: 10.1186/s13195-021-00814-7.
4
Cerebrospinal Fluid Neurofilament Light Predicts Risk of Dementia Onset in Cognitively Healthy Individuals and Rate of Cognitive Decline in Mild Cognitive Impairment: A Prospective Longitudinal Study.脑脊液神经丝轻链可预测认知健康个体的痴呆发病风险及轻度认知障碍个体的认知衰退速度:一项前瞻性纵向研究
Biomedicines. 2022 Apr 30;10(5):1045. doi: 10.3390/biomedicines10051045.
5
Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment.改良的地中海生酮饮食通过调节肠道微生物组和短链脂肪酸来与轻度认知障碍患者阿尔茨海默病标志物相关联。
EBioMedicine. 2019 Sep;47:529-542. doi: 10.1016/j.ebiom.2019.08.032. Epub 2019 Aug 30.
6
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.血液磷酸化 tau 181 作为阿尔茨海默病的生物标志物:使用来自四个前瞻性队列的数据进行的诊断性能和预测模型研究。
Lancet Neurol. 2020 May;19(5):422-433. doi: 10.1016/S1474-4422(20)30071-5.
7
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.阿尔茨海默病临床谱系中淀粉样蛋白异常的患病率估计
JAMA Neurol. 2022 Mar 1;79(3):228-243. doi: 10.1001/jamaneurol.2021.5216.
8
Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer's disease continuum.脑脊液代谢相关蛋白在阿尔茨海默病连续体中的潜在诊断价值。
Alzheimers Res Ther. 2023 Jul 15;15(1):124. doi: 10.1186/s13195-023-01269-8.
9
A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other Dementias.神经丝轻链、神经胶质纤维酸性蛋白和神经元五聚素-2 的联合检测可区分额颞叶痴呆和其他类型痴呆。
J Alzheimers Dis. 2022;90(1):363-380. doi: 10.3233/JAD-220318.
10
Integrating proteomic, lipidomic and metabolomic data to construct a global metabolic network of lethal ventricular tachyarrhythmias (LVTA) induced by aconitine.整合蛋白质组学、脂质组学和代谢组学数据,构建乌头碱诱导致死性室性心律失常(LVTA)的全局代谢网络。
J Proteomics. 2021 Feb 10;232:104043. doi: 10.1016/j.jprot.2020.104043. Epub 2020 Nov 5.

引用本文的文献

1
Identification and Validation of New Molecular Subtypes within the Early and Late Mild Cognitive Impairment Stages of Alzheimer's Disease.阿尔茨海默病早期和晚期轻度认知障碍阶段新分子亚型的识别与验证
medRxiv. 2025 May 24:2023.04.06.23288268. doi: 10.1101/2023.04.06.23288268.
2
Radiomic and proteomic signatures of body mass index on brain ageing and Alzheimer's-like patterns of brain atrophy.体重指数对脑老化及阿尔茨海默病样脑萎缩模式的放射组学和蛋白质组学特征
EBioMedicine. 2025 Jun;116:105763. doi: 10.1016/j.ebiom.2025.105763. Epub 2025 May 27.
3
Predictive Models for the Transition from Mild Neurocognitive Disorder to Major Neurocognitive Disorder: Insights from Clinical, Demographic, and Neuropsychological Data.从轻度神经认知障碍向重度神经认知障碍转变的预测模型:来自临床、人口统计学和神经心理学数据的见解
Biomedicines. 2024 Jun 1;12(6):1232. doi: 10.3390/biomedicines12061232.

本文引用的文献

1
Cerebrospinal fluid proteomics in patients with Alzheimer's disease reveals five molecular subtypes with distinct genetic risk profiles.阿尔茨海默病患者的脑脊液蛋白质组学研究揭示了具有不同遗传风险特征的五个分子亚型。
Nat Aging. 2024 Jan;4(1):33-47. doi: 10.1038/s43587-023-00550-7. Epub 2024 Jan 9.
2
Deep learning analysis of UPLC-MS/MS-based metabolomics data to predict Alzheimer's disease.基于超高效液相色谱-串联质谱的代谢组学数据的深度学习分析以预测阿尔茨海默病
J Neurol Sci. 2023 Oct 15;453:120812. doi: 10.1016/j.jns.2023.120812. Epub 2023 Sep 22.
3
Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer's disease.脑脊液蛋白质组学定义常染色体显性阿尔茨海默病的自然史。
Nat Med. 2023 Aug;29(8):1979-1988. doi: 10.1038/s41591-023-02476-4. Epub 2023 Aug 7.
4
Cerebrospinal fluid levels of fatty acid-binding protein 3 are associated with likelihood of amyloidopathy in cognitively healthy individuals.认知健康个体中,脑脊液脂肪酸结合蛋白3水平与淀粉样病变的可能性相关。
Alzheimers Dement (Amst). 2022 Dec 4;14(1):e12377. doi: 10.1002/dad2.12377. eCollection 2022.
5
Unified epigenomic, transcriptomic, proteomic, and metabolomic taxonomy of Alzheimer's disease progression and heterogeneity.阿尔茨海默病进展和异质性的统一表观基因组学、转录组学、蛋白质组学和代谢组学分类法。
Sci Adv. 2022 Nov 16;8(46):eabo6764. doi: 10.1126/sciadv.abo6764. Epub 2022 Nov 18.
6
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019.2019 年全球痴呆症患病率估计及 2050 年预测患病率:2019 年全球疾病负担研究分析。
Lancet Public Health. 2022 Feb;7(2):e105-e125. doi: 10.1016/S2468-2667(21)00249-8. Epub 2022 Jan 6.
7
Integrative metabolomics-genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease.整合代谢组学-基因组学方法揭示阿尔茨海默病的关键代谢途径和调控因子。
Alzheimers Dement. 2022 Jun;18(6):1260-1278. doi: 10.1002/alz.12468. Epub 2021 Nov 10.
8
CSF Proteomic Alzheimer's Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals.认知功能正常的淀粉样蛋白阴性个体中脑脊液蛋白质组学阿尔茨海默病预测亚型
Proteomes. 2021 Aug 2;9(3):36. doi: 10.3390/proteomes9030036.
9
Plasma lipidome is dysregulated in Alzheimer's disease and is associated with disease risk genes.阿尔茨海默病患者的血浆脂质组失调,并与疾病风险基因相关。
Transl Psychiatry. 2021 Jun 7;11(1):344. doi: 10.1038/s41398-021-01362-2.
10
Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer's disease.纵向脑脊液蛋白质组学鉴定 NPTX2 为阿尔茨海默病的预后生物标志物。
Alzheimers Dement. 2021 Dec;17(12):1976-1987. doi: 10.1002/alz.12353. Epub 2021 May 13.

认知衰退状态之间多组学的特征与鉴别能力

Signatures and Discriminative Abilities of Multi-Omics between States of Cognitive Decline.

作者信息

Anagnostakis Filippos, Kokkorakis Michail, Walker Keenan A, Davatzikos Christos

机构信息

Department of Medical and Surgical Sciences, Alma Mater University of Bologna, 40126 Bologna, Italy.

Centre for Biomedical Image Computing and Analytics, University of Pennsylvania, Philadelphia, PA 19104, USA.

出版信息

Biomedicines. 2024 Apr 23;12(5):941. doi: 10.3390/biomedicines12050941.

DOI:10.3390/biomedicines12050941
PMID:38790903
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11118245/
Abstract

Dementia poses a substantial global health challenge, warranting an exploration of its intricate pathophysiological mechanisms and potential intervention targets. Leveraging multi-omic technology, this study utilizes data from 2251 participants to construct classification models using lipidomic, gut metabolomic, and cerebrospinal fluid (CSF) proteomic markers to distinguish between the states of cognitive decline, namely, the cognitively unimpaired state, mild cognitive impairment, and dementia. The analysis identifies three CSF proteins (apolipoprotein E, neuronal pentraxin-2, and fatty-acid-binding protein), four lipids (DEDE.18.2, DEDE.20.4, LPC.O.20.1, and LPC.P.18.1), and five serum gut metabolites (Hyodeoxycholic acid, Glycohyodeoxycholic acid, Hippuric acid, Glyceric acid, and Glycodeoxycholic acid) capable of predicting dementia prevalence from cognitively unimpaired participants, achieving Area Under the Curve (AUC) values of 0.879 (95% CI: 0.802-0.956), 0.766 (95% CI: 0.700-0.835), and 0.717 (95% CI: 0.657-0.777), respectively. Furthermore, exclusively three CSF proteins exhibit the potential to predict mild cognitive impairment prevalence from cognitively unimpaired subjects, with an AUC of 0.760 (95% CI: 0.691-0.828). In conclusion, we present novel combinations of lipids, gut metabolites, and CSF proteins that showed discriminative abilities between the states of cognitive decline and underscore the potential of these molecules in elucidating the mechanisms of cognitive decline.

摘要

痴呆症是一项重大的全球健康挑战,有必要对其复杂的病理生理机制和潜在干预靶点进行探索。本研究利用多组学技术,使用来自2251名参与者的数据,构建了分类模型,采用脂质组学、肠道代谢组学和脑脊液(CSF)蛋白质组学标记物来区分认知衰退状态,即认知未受损状态、轻度认知障碍和痴呆症。分析确定了三种脑脊液蛋白(载脂蛋白E、神经元五聚体蛋白-2和脂肪酸结合蛋白)、四种脂质(DEDE.18.2、DEDE.20.4、LPC.O.20.1和LPC.P.18.1)以及五种血清肠道代谢物(猪去氧胆酸、甘氨猪去氧胆酸、马尿酸、甘油酸和甘氨脱氧胆酸),这些物质能够从认知未受损的参与者中预测痴呆症患病率,曲线下面积(AUC)值分别为0.879(95%置信区间:0.802-0.956)、0.766(95%置信区间:0.700-0.835)和0.717(95%置信区间:0.657-0.777)。此外,只有三种脑脊液蛋白具有从认知未受损受试者中预测轻度认知障碍患病率的潜力,AUC为0.760(95%置信区间:0.691-0.828)。总之,我们提出了脂质、肠道代谢物和脑脊液蛋白的新组合,这些组合在认知衰退状态之间显示出判别能力,并强调了这些分子在阐明认知衰退机制方面的潜力。